secukinumab,adalimumab,tofacitinib,etanercept,ixekizumab,infliximab,golimumab,certolizumab,upadacitinib,bimekizumab
janssen,pfizer,ucb pharmaceuticals,novartis,amgen,abbvie,eli lilly
['bimekizumab', 'ibd', 'ixekizumab', 'etanercept', 'adalimumab', 'secukinumab', 'certolizumab', 'infliximab', 'upadacitinib', 'tofa', 'tofacitinib', 'golimumab']
we need more agents for uveitis! excited to see that il17 a/f might work?! upadacitinib recently approved for ibd.
#eular2023 
Rheumatologist and life long learner 🤓. Citizen of the world.Special shoutout to my students and patients, you got this💪🏽. 😷